Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter

International Journal of Molecular Medicine

Volumn 18, Issue 5, 2006, Pages 901-908

  Määttä, Ann Marie ^a   Korja, Sanna ^a   Venhoranta, Heli ^a   Hakkarainen, Tanja ^a   Pirinen, Eija ^a   Heikkinen, Sami ^a   Pellinen, Riikka ^a   Mäkinen, Kimmo ^b   Wahlfors, Jarmo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Lentivirus vector; Promoter; Targeting

Indexed keywords

HEXOKINASE; THYMIDINE KINASE;

ANIMAL; ARTICLE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; LENTIVIRINAE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; MOUSE; NEOPLASM; PROMOTER REGION; SUICIDE TRANSGENE; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HEXOKINASE; HUMANS; LENTIVIRUS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASMS; PROMOTER REGIONS (GENETICS); THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 35548939443     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.5.901     Document Type: Article

References (20)

1. Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R, Langford G, Murray N and Yla-Herttuala S: AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10: 967-972, 2004.
2. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46: 5276-5281, 1986.
3. Agh M, Hochberg F and Breakefield XO: Prodrug activation enzymes in cancer gene therapy. J Gene Med 2: 148-164, 2000.
4. Hasegawa Y, Emi N, Shimokata K, Abe A, Kawabe T, Hasegawa T, Kirioka T and Saito H: Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors. Am J Respir Cell Mol Biol 8: 655-661, 1993.
5. Maatta AM, Tenhunen A, Pasanen T, Merilainen O, Pellinen R, Makinen K, Alhava E and Wahlfors J: Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. Int J Oncol 24: 943-949, 2004.
6. Gottesman MM: Cancer gene therapy: an awkward adolescence. Cancer Gene Ther 10: 501-508, 2003.
7. Robson T and Hirst DG: Transcriptional targeting in cancer gene therapy. J Biomed Biotechnol 2003: 110-137, 2003.
8. Rempel A, Mathupala SP and Perdersen PL: Glucose catabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP. FEBS Lett 385: 233-237, 1996. (Pubitemid 26167464)
9. Mathupala SP, Rempel A and Pedersen PL: Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J Biol Chem 270: 16918-16925, 1995.
10. Katabi MM, Chan HLB, Karp SE and Batist G: Hexokinase type II: A novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells. Hum Gene Ther 10: 155-164, 1999.
11. Pirinen E, Heikkinen S, Malkki M, Deeb SS, Janne J and Laakso M: Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb. Biochim Biophys Acta 1676: 149-154, 2004.
12. Merilainen O, Hakkarainen T, Wahlfors T, Pellinen R and Wahlfors J: HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct. Int J Oncol 27: 203-208, 2005.
13. Loimas S, Wahlfors J and Janne J: Herpes simplex virus thymidine kinase green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy. Biotechniques 24: 614-618, 1998. (Pubitemid 28227468)
14. Heikkinen S, Suppola S, Malkki M, Deeb SS, Janne J and Laakso M: Mouse hexokinase II gene: structure, cDNA, promoter analysis, and expression pattern. Mamm Genome 11: 91-96, 2000. (Pubitemid 30054409)
15. Griffin LD, Gelb BD, Adams V and McCabe ER: Developmental expression of hexokinase 1 in the rat. Biochim Biophys Acta 1129: 309-317, 1992.
16. Katzen HM and Schimke RT: Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and properties. Proc Natl Acad Sci USA 54: 1218-1225, 1965.
17. Sebastian S and Kenkare UW: Expression of two type II-like tumor hexokinase RNA transcripts in cancer cell lines. Tumour Biol 19: 253-260, 1998.
18. Mathupala SP, Rempel A and Pedersen PL: Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29: 339-343, 1997.
19. Nakashima RA, Paggi MG, Scott LJ and Pedersen PL: Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res 48: 913-919, 1988.
20. Drake RR, Pitlyk K, McMasters RA, Mercer KE, Young H and Moyer MP: Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line. Mol Ther 2: 515-523, 2000.